Four patients received the jab at the Kaiser Permanente research facility in Seattle, Washington.
Experts say it will still take many months to know if this vaccine, or others also in research, will work.
The first person to get the jab on Monday was a 43-year-old mother-of-two from Seattle.
Scientists around the world are fast-tracking research.